Acknowledgements
Håkan
RITTER
M.A. was supported by the Lundbeck Foundation Professor Grant (R310-2018-3711). The authors thank Dr Haidar Al-Khazali, Dr Faisal Mohammad Amin, Dr Håkan Ashina, Dr Hande Coskun, Dr Afrim Iljazi, Dr Lanfranco Pellesi, Dr Henrik Winther Schytz, Dr Nita Katarina Frifelt Wienholtz, pharmacologist Fatima Azzahra Elbahi and lab technicians Lene Elkjær and Winnie Grønning for their assistance during the conduct of this study. Statistical support was provided by Shannon Ritter, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.